LEADER 01377nam--2200421---450-
001 990001104240203316
005 20030220121425.0
010   $a0-8247-9981-X
035   $a000110424
035   $aUSA01000110424
035   $a(ALEPH)000110424USA01
035   $a000110424
100   $a20021118d1997----km-y0enga50------ba
101 0 $aeng
102   $aUS
105   $ay|||z|||001yy
200 1 $aDevelopment of biopharmaceutical parenteral dosage forms$fedited by John A. Bontempo
210   $aNew York [etc.]$cM. Dekker$dcopyr. 1997
215   $aVIII, 248 p.$d23 cm
225 2 $aDrugs and the pharmaceutical sciences$v85
410  0$12001$aDrugs and the pharmaceutical sciences$v85
606 0 $aMedicinali$xSomministrazione
606 0 $aBiotecnologia$xImpiego in farmacologia
606  1$aSoluzioni parenterali
676   $a615.6
702  1$aBONTEMPO,$bJohn A.
801  0$aIT$bSalbc$cISBD
912   $a990001104240203316
951   $a615.6 DEV$b3209 FAR$c615$d00099246
959   $aBK
969   $aFAR
979   $aMARIA$b10$c20021118$lUSA01$h1342
979   $aCHIARA$b90$c20030219$lUSA01$h1715
979   $aCHIARA$b90$c20030219$lUSA01$h1715
979   $aCHIARA$b90$c20030220$lUSA01$h1214
979   $aPATRY$b90$c20040406$lUSA01$h1716
996   $aDevelopment of biopharmaceutical parenteral dosage forms$9977610
997   $aUNISA